Hakutulokset - Satish K. Garg

Tarkenna hakua
  1. 1
    Relationship of Fasting and Hourly Blood Glucose Levels to HbA1c Values

    Relationship of Fasting and Hourly Blood Glucose Levels to HbA1c Values Tekijä Satish K. Garg, Lois Jovanovič

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Managing diabetes in the digital age

    Managing diabetes in the digital age Tekijä Viral N. Shah, Satish K. Garg

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults With Type 1 Diabetes

    Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults With Type 1 Diabetes Tekijä Satish K. Garg, Sherwyn Schwartz, Steven V. Edelman

    Julkaistu 2004
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Ever-Increasing Insulin-Requiring Patients Globally

    Ever-Increasing Insulin-Requiring Patients Globally Tekijä Satish K. Garg, Amanda Rewers, Halis Kaan Aktürk

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Editorial
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases

    Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases Tekijä Abdulhalim M. Almurashi, Erika Rodriguez, Satish K. Garg

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Diabetes and cancer: two diseases with obesity as a common risk factor

    Diabetes and cancer: two diseases with obesity as a common risk factor Tekijä Satish K. Garg, Harold M. Maurer, Kristen Reed, RAJENDRANATH SELAGAMSETTY

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol

    Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol Tekijä Satish K. Garg, Anne L. Peters, John B. Buse, Thomas Danne

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes

    Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes Tekijä R. Paul Wadwa, Lori M. Laffel, Viral N. Shah, Satish K. Garg

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator

    Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator Tekijä Viral N. Shah, Lori M. Laffel, R. Paul Wadwa, Satish K. Garg

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials

    Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials Tekijä Cyrus Desouza, Bertrand Cariou, Satish K. Garg, Nanna L. Lausvig, Andrea Navarria, Vivian Fonseca

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic Visits

    Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic Visits Tekijä H. Peter Chase, Jerusha Pearson, Clare Wightman, Mary D. Roberts, Adam D. Oderberg, Satish K. Garg

    Julkaistu 2003
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor

    Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor Tekijä Satish K. Garg, Howard Zisser, Sherwyn Schwartz, Timothy S. Bailey, Roy A. Kaplan, Samuel L. Ellis, Lois Jovanovič

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study

    Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study Tekijä María J. Redondo, Marian Rewers, Liping Yu, Satish K. Garg, C.C. Pilcher, Robert B. Elliott, George S. Eisenbarth

    Julkaistu 1999
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy

    Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy Tekijä Satish K. Garg, Mary Voelmle, Christie Beatson, Hayley A. Miller, Lauren B. Crew, Brandon J. Freson, R. M. Hazenfield

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes

    Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes Tekijä Satish K. Garg, Julio Rosenstock, Bernard L. Silverman, Bin Sun, Christopher S. Konkoy, Amparo de la Peña, Douglas B. Muchmore

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 Diabetes

    A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 Diabetes Tekijä Steve Edelman, Satish K. Garg, Juan P. Frías, David Maggs, Yan Wang, Bei Zhang, S. Strobel, Karen Lutz, Orville Kolterman

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study

    Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study Tekijä Ram Weiss, Satish K. Garg, Bruce W. Bode, Timothy S. Bailey, Andrew Ahmann, Kenneth A. Schultz, John Welsh, John Shin

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis

    Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis Tekijä Satish K. Garg, Irl B. Hirsch, Enrico Repetto, Janet K. Snell‐Bergeon, Brian Ulmer, Christopher Perkins, Richard M. Bergenstal

    Julkaistu 2024
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Reductions in Insulin Resistance are Mediated Primarily via Weight Loss in Subjects With Type 2 Diabetes on Semaglutide

    Reductions in Insulin Resistance are Mediated Primarily via Weight Loss in Subjects With Type 2 Diabetes on Semaglutide Tekijä Vivian Fonseca, Matthew Capehorn, Satish K. Garg, Esteban Jódar Gimeno, Oluf H. Hansen, Anders G. Holst, Gurudutt Nayak, Jochen Seufert

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    The Impact of the Diabetes Control and Complications Trial and Humalog Insulin on Glycohemoglobin Levels and Severe Hypoglycemia in Type 1 Diabetes

    The Impact of the Diabetes Control and Complications Trial and Humalog Insulin on Glycohemoglobin Levels and Severe Hypoglycemia in Type 1 Diabetes Tekijä H. Peter Chase, Tai M. Lockspeiser, Ben Peery, Mark D. Shepherd, Todd A. MacKenzie, James H. Anderson, Satish K. Garg

    Julkaistu 2001
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: